warrants
-
Financial
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds
BURLINGTON, Mass., August 2, 2024–(BUSINESS WIRE)–Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic…
Read More » -
Financial
BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8.1 Million Gross Proceeds Priced At-the-Market
MELVILEE, N.Y., Feb. 06, 2024 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (NASDAQ: BRTX), a clinical stage…
Read More » -
Financial
Early Warning Report – Acquisition of Aurora Spine Corporation Shares
Toronto, Ontario, Oct. 27, 2023 (GLOBE NEWSWIRE) — David Rosenkrantz (“Acquiror”) announces that he has filed an early warning report…
Read More » -
Financial
Xtant Medical Announces $9.75 Million Private Investment
Upon completion of first closing, Stavros Vizirgianakis to become Non-Executive Chairman BELGRADE, Mont., Aug. 24, 2022 (GLOBE NEWSWIRE) — Xtant…
Read More » -
Financial
Ortho Regenerative Technologies Closes Oversubscribed Non-Brokered Private Placement for $3.2 Million
Proceeds to be used to accelerate the ORTHO-R Phase I/II US Clinical trial for rotator cuff tear repairInsiders contribute approximately $560,000 MONTREAL, April…
Read More » -
Financial
Ortho Regenerative Technologies Announces $3 Million Non-Brokered Private Placement of Units
MONTREAL, Feb. 11, 2022 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) (“Ortho” or the “Company“), a clinical-stage orthobiologics company focused on…
Read More » -
Financial
EARLY WARNING PRESS RELEASE – Acquisition of Aurora Spine Corporation Shares
TORONTO, Feb. 07, 2020 (GLOBE NEWSWIRE) — David Rosenkrantz (“Acquiror”) announces that he has filed an early warning report under…
Read More » -
Biologics
Asterias Biotherapeutics Extends the Expiration Date of Certain Warrants and Provides Update on Cash Position
FREMONT, Calif., Feb. 3, 2017 /PRNewswire/ — Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of regenerative…
Read More » -
Financial
Amedica Announces Proposed Public Offering of Common Stock and Warrants
SALT LAKE CITY, UT–(Marketwired – Jan 18, 2017) – Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon…
Read More » -
Financial
Safe Orthopaedics announces having raised approximately 500,000 euros in the form of convertible notes with warrants attached subscribed by IdInvest Partners
Eragny-sur-Oise, France, July 26, 2016 – SAFE ORTHOPAEDICS (FR0012452746 – SAFOR), a company offering innovative ranges of sterile implants combined…
Read More » -
Medical device co Mazor raises double planned sum
Mazor Surgical Technologies Ltd. (TASE:MZOR) raised NIS 48 million in shares and warrants in the public tender of its offering.…
Read More »